Similarly, TTN presented an obvious downregulation in CRC tissues, relative to normal controls (2.61 ± 3.82 vs. 0.31 ± 0.41, p < 0.01) (Figure 1D). The gene discussed is TTN; the disease is colorectal carcinoma.